296 related articles for article (PubMed ID: 29685397)
21. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
Palms DL; Jacob JT
Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
[TBL] [Abstract][Full Text] [Related]
22. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.
Barr DA; Semple L; Seaton RA
Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
[TBL] [Abstract][Full Text] [Related]
24. Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection.
Kilinc F; Setzer M; Behmanesh B; Jussen D; Gessler F; Keil F; Kempf VAJ; Kessel J; Czabanka M; Prinz V
Sci Rep; 2023 Apr; 13(1):6863. PubMed ID: 37100824
[TBL] [Abstract][Full Text] [Related]
25. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
[TBL] [Abstract][Full Text] [Related]
26. Outpatient parenteral antimicrobial therapy today.
Paladino JA; Poretz D
Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
[TBL] [Abstract][Full Text] [Related]
27. Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards.
Durojaiye OC; Cartwright K; Ntziora F
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):58-62. PubMed ID: 30098851
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
[TBL] [Abstract][Full Text] [Related]
29. Safety of Outpatient Parenteral Antimicrobial Therapy in Children.
Fernandes P; Milliren C; Mahoney-West HM; Schwartz L; Lachenauer CS; Nakamura MM
Pediatr Infect Dis J; 2018 Feb; 37(2):157-163. PubMed ID: 28763427
[TBL] [Abstract][Full Text] [Related]
30. Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review.
Carter B; Carrol ED; Porter D; Peak M; Taylor-Robinson D; Fisher-Smith D; Blake L
BMJ Open; 2018 Nov; 8(11):e021603. PubMed ID: 30446572
[TBL] [Abstract][Full Text] [Related]
31. Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.
Shakeraneh P; Fazili T; Wang D; Gilotra T; Steele JM; Seabury RW; Miller CD; Darko W; Probst LA; Kufel WD
Pharmacotherapy; 2020 Apr; 40(4):357-362. PubMed ID: 32090347
[TBL] [Abstract][Full Text] [Related]
32. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
Gilchrist M; Seaton RA
J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
[TBL] [Abstract][Full Text] [Related]
33. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
Yong C; Fisher DA; Sklar GE; Li SC
Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.
Durojaiye OC; Slucka A; Kritsotakis EI
Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187
[TBL] [Abstract][Full Text] [Related]
35. Understanding the relationship between patient characteristics and complication in veterans discharged on parenteral antibiotic therapy.
Guenther ED; Sherman KA; Dysart CE; Haque J; Mahatme S; Gundacker ND
Res Social Adm Pharm; 2022 Oct; 18(10):3864-3866. PubMed ID: 35437231
[TBL] [Abstract][Full Text] [Related]
36. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.
Psaltikidis EM; Silva END; Bustorff-Silva JM; Moretti ML; Resende MR
Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):355-375. PubMed ID: 28776441
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy.
Hale CM; Steele JM; Seabury RW; Miller CD
J Pharm Pract; 2017 Dec; 30(6):600-605. PubMed ID: 28110617
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
